Free Trial

Albemarle (NYSE:ALB) Posts Quarterly Earnings Results, Beats Expectations By $1.71 EPS

Albemarle logo with Basic Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Big beat but margin caution: Albemarle reported Q1 EPS of $2.95 versus a $1.24 consensus and revenue of $1.43B versus ~$1.34B, yet still showed a negative net margin (-10.74%), suggesting earnings volatility or one‑time items.
  • Dividend and guidance: The board declared a quarterly dividend of $0.405/share (annualized $1.62; ex‑dividend June 12), while FY‑2026 revenue guidance was roughly in line with expectations at about $5.7–$6.0B, though EPS clarity was limited.
  • Stock reaction and insider/analyst signals: Shares slipped ~0.6% to $193.74 after the results, CEO J. Kent Masters sold 11,783 shares, and the Street consensus is a "Hold" with a $183 target despite several price‑target increases.
  • MarketBeat previews the top five stocks to own by June 1st.

Albemarle (NYSE:ALB - Get Free Report) released its quarterly earnings results on Wednesday. The specialty chemicals company reported $2.95 EPS for the quarter, beating the consensus estimate of $1.24 by $1.71, FiscalAI reports. The firm had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.34 billion. Albemarle had a negative net margin of 10.74% and a positive return on equity of 0.41%.

Albemarle Stock Down 0.6%

Shares of Albemarle stock traded down $1.08 during trading hours on Wednesday, reaching $193.74. 2,199,674 shares of the company were exchanged, compared to its average volume of 2,574,240. Albemarle has a 1 year low of $53.70 and a 1 year high of $215.71. The stock's fifty day moving average is $179.01 and its 200 day moving average is $152.97. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.57 and a current ratio of 2.23. The firm has a market cap of $22.84 billion, a PE ratio of -33.69, a PEG ratio of 1.37 and a beta of 1.36.

Albemarle Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 1st. Stockholders of record on Friday, June 12th will be given a dividend of $0.405 per share. The ex-dividend date of this dividend is Friday, June 12th. This represents a $1.62 dividend on an annualized basis and a dividend yield of 0.8%. Albemarle's dividend payout ratio is currently -28.17%.

Insider Buying and Selling at Albemarle

In other news, CEO J Kent Masters sold 11,783 shares of the company's stock in a transaction on Tuesday, March 10th. The stock was sold at an average price of $170.81, for a total transaction of $2,012,654.23. Following the sale, the chief executive officer owned 134,628 shares of the company's stock, valued at approximately $22,995,808.68. This represents a 8.05% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.42% of the company's stock.

Institutional Trading of Albemarle

Large investors have recently modified their holdings of the stock. Tiemann Investment Advisors LLC purchased a new stake in shares of Albemarle during the fourth quarter worth $218,000. J.W. Cole Advisors Inc. acquired a new position in shares of Albemarle during the fourth quarter worth $211,000. Sepio Capital LP acquired a new position in shares of Albemarle during the fourth quarter worth $211,000. Cim Investment Management Inc. acquired a new position in shares of Albemarle during the fourth quarter worth $204,000. Finally, Axxcess Wealth Management LLC acquired a new position in shares of Albemarle during the fourth quarter worth $202,000. Hedge funds and other institutional investors own 92.87% of the company's stock.

Albemarle News Summary

Here are the key news stories impacting Albemarle this week:

Wall Street Analyst Weigh In

ALB has been the topic of several analyst reports. Oppenheimer lifted their price target on shares of Albemarle from $216.00 to $222.00 and gave the company an "outperform" rating in a research report on Monday, April 13th. BMO Capital Markets boosted their target price on Albemarle from $145.00 to $210.00 and gave the company an "outperform" rating in a research report on Tuesday, January 20th. Mizuho boosted their target price on Albemarle from $156.00 to $185.00 and gave the company a "neutral" rating in a research report on Thursday, February 12th. Morgan Stanley boosted their target price on Albemarle from $170.00 to $189.00 and gave the company an "equal weight" rating in a research report on Tuesday, April 28th. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on Albemarle from $185.00 to $195.00 and gave the company a "buy" rating in a research report on Tuesday, February 17th. Thirteen investment analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, Albemarle presently has a consensus rating of "Hold" and a consensus target price of $183.00.

Read Our Latest Analysis on ALB

Albemarle Company Profile

(Get Free Report)

Albemarle Corporation is a leading global specialty chemicals company primarily engaged in the production and distribution of lithium, bromine, and catalysts. Its lithium segment supplies key components used in rechargeable batteries for electric vehicles, portable electronics, and grid storage systems. The company's bromine specialty products serve a wide range of industries, including oil and gas drilling fluids, fire safety solutions, and water treatment. In its catalysts division, Albemarle provides products for petroleum refining, chemical processing and emissions control.

Founded in 1994 as a spin-off from Ethyl Corporation, Albemarle has grown through strategic acquisitions and capacity expansions to become one of the world's foremost chemical producers.

Further Reading

Earnings History for Albemarle (NYSE:ALB)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Albemarle Right Now?

Before you consider Albemarle, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Albemarle wasn't on the list.

While Albemarle currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPOs On Wall Street’s 2026 Watchlist Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines